Validation of new detection methods for SARS CoV-2 in suspected COVID-19

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00021578

Enrollment

300

Registered

2020-04-28

Start date

2020-04-24

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

SARS CoV-2 U07.1

Interventions

Group 1: Naso-pharyngeal swab testing for SARS-CoV-2

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Medical indication to perform a mucosal swab for SARS CoV-2

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
Validation of a new detection method for SARS CoV2	—

Countries

Germany

Contacts

Public ContactMarcus Schuchmann

Medizinische Klinik I, Klinikum Konstanz

marcus.schuchmann@glkn.de+49 7531 801 1401

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026